avalere health limited
avalere health limited Company Information
Company Number
04269638
Next Accounts
Dec 2025
Shareholders
fishawack medical communications limited
Group Structure
View All
Industry
Other human health activities
Registered Address
the featherstone building, 66 city road, london, EC1Y 2AL
Website
http://facilitate-uk.comavalere health limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £5.9m based on a Turnover of £8.9m and 0.66x industry multiple (adjusted for size and gross margin).
avalere health limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £15.6m based on an EBITDA of £3.1m and a 5.08x industry multiple (adjusted for size and gross margin).
avalere health limited Estimated Valuation
Pomanda estimates the enterprise value of AVALERE HEALTH LIMITED at £49.1m based on Net Assets of £20.9m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avalere Health Limited Overview
Avalere Health Limited is a live company located in london, EC1Y 2AL with a Companies House number of 04269638. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2001, it's largest shareholder is fishawack medical communications limited with a 100% stake. Avalere Health Limited is a mature, mid sized company, Pomanda has estimated its turnover at £8.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Avalere Health Limited Health Check
Pomanda's financial health check has awarded Avalere Health Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
3 Weak
Size
annual sales of £8.9m, make it larger than the average company (£725k)
£8.9m - Avalere Health Limited
£725k - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (7.2%)
9% - Avalere Health Limited
7.2% - Industry AVG
Production
with a gross margin of 45.6%, this company has a comparable cost of product (38.6%)
45.6% - Avalere Health Limited
38.6% - Industry AVG
Profitability
an operating margin of 34.3% make it more profitable than the average company (5.1%)
34.3% - Avalere Health Limited
5.1% - Industry AVG
Employees
with 115 employees, this is above the industry average (18)
- Avalere Health Limited
18 - Industry AVG
Pay Structure
on an average salary of £26.4k, the company has an equivalent pay structure (£26.4k)
- Avalere Health Limited
£26.4k - Industry AVG
Efficiency
resulting in sales per employee of £77.6k, this is more efficient (£45.6k)
- Avalere Health Limited
£45.6k - Industry AVG
Debtor Days
it gets paid by customers after 61 days, this is later than average (20 days)
61 days - Avalere Health Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (18 days)
2 days - Avalere Health Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Avalere Health Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (126 weeks)
6 weeks - Avalere Health Limited
126 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.2%, this is a lower level of debt than the average (22.4%)
7.2% - Avalere Health Limited
22.4% - Industry AVG
AVALERE HEALTH LIMITED financials
Avalere Health Limited's latest turnover from March 2024 is £8.9 million and the company has net assets of £20.9 million. According to their latest financial statements, we estimate that Avalere Health Limited has 115 employees and maintains cash reserves of £217.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8,925,483 | 7,166,831 | 6,842,506 | 6,834,198 | 4,059,538 | 3,953,633 | 4,009,452 | 4,692,864 | 4,860,416 | 5,233,689 | 5,917,783 | ||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 4,859,083 | 5,034,556 | 4,113,018 | 3,557,541 | 2,264,106 | 2,243,467 | 2,294,795 | 2,998,944 | 3,544,549 | 4,177,580 | 3,698,234 | ||||
| Gross Profit | 4,066,400 | 2,132,275 | 2,729,488 | 3,276,657 | 1,795,432 | 1,710,166 | 1,714,657 | 1,693,920 | 1,315,867 | 1,056,109 | 2,219,549 | ||||
| Admin Expenses | 1,004,240 | 204,422 | 259,500 | 789,252 | 403,216 | 556,132 | 515,746 | -284,613 | 480,557 | 563,514 | 1,323,436 | ||||
| Operating Profit | 3,062,160 | 1,927,853 | 2,469,988 | 2,487,405 | 1,392,216 | 1,154,034 | 1,198,911 | 1,978,533 | 835,310 | 492,595 | 896,113 | ||||
| Interest Payable | 23,180 | 11,496 | 13,353 | 7,910 | 9,662 | 6,531 | 91,866 | ||||||||
| Interest Receivable | 1,904,155 | 849,151 | 418,471 | 264,835 | 123 | 9,286 | |||||||||
| Pre-Tax Profit | 4,943,135 | 2,765,508 | 2,875,106 | 2,744,330 | 1,392,216 | 1,144,372 | 1,198,911 | 1,978,656 | 835,310 | 486,064 | 813,533 | ||||
| Tax | 229 | 280,553 | -278,395 | 67,830 | 191,369 | -218,174 | 357,805 | -438,259 | 14,345 | -54,028 | -232,939 | ||||
| Profit After Tax | 4,943,364 | 3,046,061 | 2,596,711 | 2,812,160 | 1,583,585 | 926,198 | 1,556,716 | 1,540,397 | 849,655 | 432,036 | 580,594 | ||||
| Dividends Paid | 411,395 | ||||||||||||||
| Retained Profit | 4,943,364 | 3,046,061 | 2,596,711 | 2,812,160 | 1,583,585 | 514,803 | 1,556,716 | 1,540,397 | 849,655 | 432,036 | 580,594 | ||||
| Employee Costs | 734,556 | 616,892 | 971,812 | ||||||||||||
| Number Of Employees | 5 | 9 | 16 | 13 | 14 | 20 | |||||||||
| EBITDA* | 3,064,920 | 1,932,948 | 2,482,086 | 2,499,616 | 1,402,013 | 1,155,715 | 1,218,478 | 1,998,908 | 860,410 | 535,535 | 950,476 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 10,969 | 13,729 | 18,824 | 30,922 | 43,133 | 606 | 2,287 | 19,812 | 38,095 | 58,596 | 89,551 | 132,076 | 188,030 | 208,015 | 262,956 |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 10,969 | 13,729 | 18,824 | 30,922 | 43,133 | 606 | 2,287 | 19,812 | 38,095 | 58,596 | 89,551 | 132,076 | 188,030 | 208,015 | 262,956 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 1,503,811 | 1,313,856 | 745,907 | 1,295,022 | 1,169,244 | 497,810 | 282,073 | 1,240,508 | 1,131,293 | 955,450 | 805,306 | 1,422,612 | 1,175,253 | 733,736 | 650,331 |
| Group Debtors | 18,951,067 | 15,417,982 | 13,201,599 | 9,277,351 | 6,668,049 | 5,046,052 | 4,983,601 | 3,222,411 | 1,562,451 | 800,629 | |||||
| Misc Debtors | 1,839,911 | 1,320,899 | 1,232,217 | 1,267,308 | 1,033,816 | 811,710 | 768,418 | 1,157,926 | 795,803 | 381,000 | 834,882 | ||||
| Cash | 217,748 | 1,133,335 | 636,278 | 363,989 | 152,414 | 1,130,874 | 398,307 | 440,585 | 800,053 | 528,159 | 432,661 | 511,746 | 377,494 | 530,729 | 328,012 |
| misc current assets | |||||||||||||||
| total current assets | 22,512,537 | 19,186,072 | 15,816,001 | 12,203,670 | 9,023,523 | 7,486,446 | 6,432,399 | 6,061,430 | 4,289,600 | 2,665,238 | 2,072,849 | 1,934,358 | 1,552,747 | 1,264,465 | 978,343 |
| total assets | 22,523,506 | 19,199,801 | 15,834,825 | 12,234,592 | 9,066,656 | 7,487,052 | 6,434,686 | 6,081,242 | 4,327,695 | 2,723,834 | 2,162,400 | 2,066,434 | 1,740,777 | 1,472,480 | 1,241,299 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 34,972 | 33,035 | 51,053 | 28,296 | 38,591 | 208,137 | 152,334 | 113,154 | 150,037 | 75,533 | 299,360 | 1,177,943 | 1,004,421 | 825,964 | 670,515 |
| Group/Directors Accounts | 2,691,455 | 2,084,835 | 1,480,864 | 718,407 | 582,081 | 602,843 | 415,808 | 44,977 | 21,473 | ||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,588,287 | 518,428 | 788,115 | 411,321 | 807,707 | 778,468 | 305,620 | 1,735,107 | 1,855,905 | 1,197,089 | 723,955 | ||||
| total current liabilities | 1,623,259 | 3,242,918 | 2,924,003 | 1,920,481 | 1,564,705 | 1,568,686 | 1,060,797 | 2,264,069 | 2,050,919 | 1,294,095 | 1,023,315 | 1,177,943 | 1,004,421 | 825,964 | 670,515 |
| loans | 144,000 | ||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 144,000 | 288,000 | 388,000 | 388,000 | |||||||||||
| provisions | 2,618 | 19,014 | |||||||||||||
| total long term liabilities | 2,618 | 144,000 | 144,000 | 288,000 | 388,000 | 407,014 | |||||||||
| total liabilities | 1,623,259 | 3,242,918 | 2,924,003 | 1,920,481 | 1,564,705 | 1,568,686 | 1,060,797 | 2,264,069 | 2,050,919 | 1,296,713 | 1,167,315 | 1,321,943 | 1,292,421 | 1,213,964 | 1,077,529 |
| net assets | 20,900,247 | 15,956,883 | 12,910,822 | 10,314,111 | 7,501,951 | 5,918,366 | 5,373,889 | 3,817,173 | 2,276,776 | 1,427,121 | 995,085 | 744,491 | 448,356 | 258,516 | 163,770 |
| total shareholders funds | 20,900,247 | 15,956,883 | 12,910,822 | 10,314,111 | 7,501,951 | 5,918,366 | 5,373,889 | 3,817,173 | 2,276,776 | 1,427,121 | 995,085 | 744,491 | 448,356 | 258,516 | 163,770 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 3,062,160 | 1,927,853 | 2,469,988 | 2,487,405 | 1,392,216 | 1,154,034 | 1,198,911 | 1,978,533 | 835,310 | 492,595 | 896,113 | ||||
| Depreciation | 2,760 | 5,095 | 12,098 | 12,211 | 9,797 | 1,681 | 19,567 | 20,375 | 25,100 | 42,940 | 54,363 | 68,813 | 65,491 | 58,224 | 67,616 |
| Amortisation | |||||||||||||||
| Tax | 229 | 280,553 | -278,395 | 67,830 | 191,369 | -218,174 | 357,805 | -438,259 | 14,345 | -54,028 | -232,939 | ||||
| Stock | |||||||||||||||
| Debtors | 4,242,052 | 2,873,014 | 3,340,042 | 2,968,572 | 2,515,537 | 321,480 | 413,247 | 2,131,298 | 1,352,468 | 2,137,079 | 217,576 | 247,359 | 441,517 | 83,405 | 650,331 |
| Creditors | 1,937 | -18,018 | 22,757 | -10,295 | -169,546 | 55,803 | 39,180 | -36,883 | 74,504 | 75,533 | -878,583 | 173,522 | 178,457 | 155,449 | 670,515 |
| Accruals and Deferred Income | 1,069,859 | -269,687 | 376,794 | -396,386 | 29,239 | 472,848 | -1,429,487 | -120,798 | 658,816 | 1,197,089 | 723,955 | ||||
| Deferred Taxes & Provisions | -2,618 | 2,618 | -19,014 | 19,014 | |||||||||||
| Cash flow from operations | -105,107 | -947,218 | -736,800 | -807,807 | -1,062,462 | 1,144,712 | -227,271 | -728,330 | 252,989 | -380,332 | 345,333 | ||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -2,691,455 | 606,620 | 603,971 | 762,457 | 136,326 | -20,762 | 187,035 | 370,831 | 23,504 | 21,473 | |||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | 144,000 | ||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | -144,000 | -144,000 | -100,000 | 388,000 | |||||||||||
| share issue | |||||||||||||||
| interest | 1,880,975 | 837,655 | 405,118 | 256,925 | -9,662 | 123 | -6,531 | -82,580 | |||||||
| cash flow from financing | -810,480 | 1,444,275 | 1,009,089 | 1,019,382 | 136,326 | -750 | 187,035 | 370,954 | 23,504 | 1,010,027 | -412,580 | ||||
| cash and cash equivalents | |||||||||||||||
| cash | -915,587 | 497,057 | 272,289 | 211,575 | -978,460 | 732,567 | -42,278 | -359,468 | 271,894 | 528,159 | -79,085 | 134,252 | -153,235 | 202,717 | 328,012 |
| overdraft | |||||||||||||||
| change in cash | -915,587 | 497,057 | 272,289 | 211,575 | -978,460 | 732,567 | -42,278 | -359,468 | 271,894 | 528,159 | -79,085 | 134,252 | -153,235 | 202,717 | 328,012 |
avalere health limited Credit Report and Business Information
Avalere Health Limited Competitor Analysis
Perform a competitor analysis for avalere health limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in EC1Y area or any other competitors across 12 key performance metrics.
avalere health limited Ownership
AVALERE HEALTH LIMITED group structure
Avalere Health Limited has no subsidiary companies.
Ultimate parent company
2 parents
AVALERE HEALTH LIMITED
04269638
avalere health limited directors
Avalere Health Limited currently has 6 directors. The longest serving directors include Mrs Gail Flockhart (Nov 2021) and Mr Jonathan Koch (Nov 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Gail Flockhart | United Kingdom | 60 years | Nov 2021 | - | Director |
| Mr Jonathan Koch | United Kingdom | 50 years | Nov 2021 | - | Director |
| Mr Brendan Ferretti | England | 45 years | Jun 2022 | - | Director |
| Mr John Gransee | United Kingdom | 59 years | Jan 2024 | - | Director |
| Mrs Harriet Shurville | United Kingdom | 38 years | Jan 2025 | - | Director |
| Amar Urhekar | United Kingdom | 50 years | Jan 2025 | - | Director |
P&L
March 2024turnover
8.9m
+25%
operating profit
3.1m
+59%
gross margin
45.6%
+53.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
20.9m
+0.31%
total assets
22.5m
+0.17%
cash
217.7k
-0.81%
net assets
Total assets minus all liabilities
avalere health limited company details
company number
04269638
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
August 2001
age
24
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
March 2024
previous names
fishawack facilitate limited (August 2024)
facilitate limited (July 2014)
accountant
-
auditor
-
address
the featherstone building, 66 city road, london, EC1Y 2AL
Bank
-
Legal Advisor
-
avalere health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to avalere health limited. Currently there are 0 open charges and 5 have been satisfied in the past.
avalere health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVALERE HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
avalere health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
